Feedback / Questions
AlloNK (GCC4001) - Artiva Biotherapeutics
https://investors.artivabio.com/News-and-Events/news/news-details/2026/Artiva-Biotherapeutics-Highlights-AlloNK-Data-Presented-at-EULAR-2026-FDA-RMAT-Designation-in-Refractory-Rheumatoid-Arthritis-and-Webcast-Today/default.aspx
Jun 8, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next